About DxLab
DxLab is a company based in Somerville (United States) founded in 2020 by Fahim Farzadfard and Louis Kang. DxLab offers products and services including COVID-19 Test and Diagnostic Tools. DxLab operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Somerville, United States
- Founders Fahim Farzadfard, Louis Kang
- SectorsHealthcare
- Email••••••••
- Website dxlab.bio
- Legal Name Dxlab Inc.
Products & Services of DxLab
DxLab offers a comprehensive portfolio of products and services, including COVID-19 Test and Diagnostic Tools.
Rapid testing for COVID-19 detection with accurate results.
Tools for early and low-cost disease detection outside labs.
People of DxLab
2 people are tracked at DxLab (2 in leadership).
| Name | Role | Group |
|---|---|---|
Fahim Farzadfard | Co-Founder | Leadership |
Louis Kang | Co-Founder | Leadership |
Complete people profiles for DxLab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of DxLab
DxLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanoporetech.com | 2005 | Oxford, United Kingdom | $1.26B | 705 | Nanopore-based electronic systems for single-molecule analysis are developed. | |
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| quantumdx.com | 2008 | Newcastle Upon Tyne, United Kingdom | $57.26M | 98 | Handheld diagnostic and sequencing devices are developed for personalized healthcare. | |
| bionano.com | 2002 | San Diego, United States | $124.2M | – | Provider of genome analysis solutions to researchers and clinicians | |
| genapsys.com | 2010 | Redwood, United States | $313.03M | 60 | Provider of DNA sequencing technologies for applied genomic testing and medical sequencing | |
| alveotechnologies.com | 2014 | Alameda, United States | $63.61M | – | Cloud-powered POC MDx device | |
| purigenbio.com | 2012 | Pleasanton, United States | $88.32M | 24 | Isotachophoresis technology is provided for nucleic acid sample preparation. | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems |
Detailed competitors of DxLab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DxLab
The website of DxLab (dxlab.bio) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 27.5% vs previous month
Similar companies to DxLab
10 companies that operate in the same segment as DxLab (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DxLab
DxLab was founded in 2020.
DxLab is headquartered in Somerville, United States. It is registered at Somerville, Massachusetts, United States.
Founded in 2020 and based in Somerville, United States, DxLab operates in the diagnostics sector. A tabletop instrument is provided by the company for screening nasal samples to detect COVID-19 and other infectious diseases. Focus is placed on point-of-care testing solutions to enable rapid diagnostics outside traditional lab settings. Operations center on biotechnology innovation for accessible health screening tools.
DxLab offers COVID-19 Test and Diagnostic Tools.
DxLab operates through Dxlab Inc..